兴齐眼药(300573.SZ)：伏立康唑滴眼液II期临床试验首例受试者入组
SHENYANG XINGQI PHARMACEUTICAL CO.(SZ:300573) Ge Long Hui A P P·2025-08-12 08:32Core Viewpoint - The company Xingqi Eye Medicine (300573.SZ) has initiated the Phase II clinical trial for its developed Voriconazole eye drops, marking a significant advancement in its research and development efforts [1] Group 1: Product Development - Voriconazole is a new generation of triazole antifungal medication, characterized by a broad antibacterial spectrum, low toxicity, and strong antibacterial efficacy [1]